Frankfurt
25.04.25
09:59 Uhr
1,340 Euro
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| DIACEUTICS Aktie jetzt für 0€ handeln | |||||
| 03.04. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS | ||
| 26.03. | Diaceutics strengthens partnership with Partner Therapeutics | 2 | Sharecast | ||
| 26.03. | Diaceutics PLC - PMx Promotional Partner Contract Enhancement | - | RNS | ||
| 03.03. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS | ||
| 31.01. | Diaceutics PLC - Purchase of Shares and PDMR Shareholding | 1 | RNS | ||
| 30.01. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan | - | RNS | ||
| 28.01. | Diaceutics-Aktien steigen aufgrund robusten Jahresumsatzwachstums | 1 | Investing.com Deutsch | ||
| 28.01. | Diaceutics shares rise on robust annual revenue growth | 1 | Investing.com | ||
| 28.01. | Diaceutics PLC - FY 2024 Trading Update - Strong Revenue Growth | - | RNS | ||
| 14.01. | IN BRIEF: Diaceutics opens new US headquarters in New Jersey | 1 | Alliance News | ||
| 14.01. | Diaceutics PLC - Diaceutics Opens US Headquarters | - | RNS | ||
| 08.01. | Diaceutics launches new engagement service with 12-month contract win | 4 | Alliance News | ||
| 08.01. | Diaceutics introduces pathology service, inks $1.8m deal | 1 | Investing.com | ||
| 08.01. | Diaceutics PLC - New Service Launched & First Contract Signed | - | RNS | ||
| 03.01. | Diaceutics PLC - PDMR Dealings & Total Voting Rights | 1 | RNS | ||
| 17.12.24 | Diaceutics wins $5.1m contract with global pharma firm | 3 | Sharecast | ||
| 17.12.24 | Diaceutics PLC - Diaceutics Wins New $5.1m Contract | - | RNS | ||
| 05.12.24 | Diaceutics awarded £1m in UKRI funding | 1 | Sharecast | ||
| 05.12.24 | Diaceutics PLC - Awarded UK Research Institute Grant Funding of £1m | - | RNS | ||
| 03.12.24 | Diaceutics PLC - Total Voting Rights | - | RNS |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 62,85 | +1,11 % | DexCom Aktie: Trotz Rückschlägen bleibt Hoffnung | Trotz starker Verluste halten Experten an DexCom fest. Der CGM-Markt wächst, doch der Wettbewerb wird härter. Bleibt die Aktie eine langfristige Chance? Die DexCom-Aktie zeigt heute ein leichtes Plus... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,639 | -0,93 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast... ► Artikel lesen | |
| SENSEONICS | 0,651 | -2,72 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately... ► Artikel lesen | |
| RESHAPE LIFESCIENCES | 0,380 | 0,00 % | ReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology | Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Patent Enables Equivalent Efficacy with 10 times Lower Energy Consumption Than Current Device Fully Compatible... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 1,475 | -100,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra | INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK... ► Artikel lesen | |
| PAVMED | 1,000 | -100,00 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results | Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies
Veris Health... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
| BRIGHTSPRING HEALTH SERVICES | 16,550 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,330 | +0,98 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS | 39,850 | 0,00 % | ANALYSE-FLASH: Barclays senkt Ziel für Fresenius SE - 'Overweight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,990 | +1,27 % | Siemens Energy haussiert, Fresenius Medical Care prallt ab: DAX-Ausblick | Der DAX hat in der vergangenen Woche weiter Boden gutgemacht. Unter dem Strich legte das größte deutsche Börsenbarometer mehr als 800 Punkte zu und schloss +4,08% höher mit 21.205 Punkten. Auf dem Kaufzettel... ► Artikel lesen | |
| GERRESHEIMER | 54,05 | +0,84 % | Jetzt oder nie! Gerresheimer-Aktie mit Turnaround und Kursziel 122,50 Euro? | ||
| UNITEDHEALTH | 376,70 | +1,03 % | UnitedHealth Group: Einsteigen oder abwarten? |
DIACEUTICS PLC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIACEUTICS PLC finden Sie auf Wallstreet Online.
